Editas Medicine's market cap is currently $170.05M. The company's EPS TTM is $-2.561; its P/E ratio is ―; Editas Medicine is scheduled to report earnings on February 26, 2025, and the estimated EPS forecast is $-0.38. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 78.12M	$ 19.71M	$ 25.54M	$ 90.73M	$ 20.53M
Gross Profit	$ -99.53M	$ 13.38M	$ 20.49M	$ -67.26M	$ -76.37M
Operating Income	$ -169.18M	$ -225.95M	$ -193.15M	$ -134.84M	$ -140.92M
EBITDA	$ -163.12M	$ -219.61M	$ -188.09M	$ -130.88M	$ -138.09M
Net Income	$ -153.22M	$ -204.35M	$ -185.11M	$ -109.41M	$ -123.47M
Balance Sheet
Cash & Short-Term Investments	$ 323.11M	$ 437.37M	$ 619.91M	$ 511.77M	$ 457.14M
Total Assets	$ 499.15M	$ 514.32M	$ 677.48M	$ 572.60M	$ 508.88M
Total Debt	$ 36.54M	$ 43.95M	$ 26.38M	$ 26.14M	$ 29.08M
Net Debt	$ -87.12M	$ -97.58M	$ -177.14M	$ -113.55M	$ -209.10M
Total Liabilities	$ 150.06M	$ 153.64M	$ 123.84M	$ 179.02M	$ 246.45M
Stockholders' Equity	$ 349.10M	$ 360.68M	$ 553.64M	$ 393.59M	$ 262.44M
Cash Flow
Free Cash Flow	$ -136.90M	$ -181.47M	$ -171.78M	$ -187.00M	$ -46.84M
Operating Cash Flow	$ -132.18M	$ -177.35M	$ -163.80M	$ -179.84M	$ -40.67M
Investing Cash Flow	$ -3.73M	$ 114.07M	$ -54.47M	$ -140.52M	$ 12.25M
Financing Cash Flow	$ 118.04M	$ 1.28M	$ 282.11M	$ 224.12M	$ 131.82M

Currency in USD

Editas Medicine Earnings and Revenue History

Income Statement >

Editas Medicine Debt to Assets

Balance Sheet >

Editas Medicine Cash Flow

Cash Flow >

Editas Medicine Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing